-
This press release contains certain forward-looking information about ZIOPHARM Oncology that is intended to be covered by the safe harbor for "forward-looking statements" provided by the Private Securities Litigation Reform Act of 1995, as amended. Forwa Full Article at Street Insider
-
The baby boom generation, those born from 1946 to 1964, are the most at risk to the bloodborne virus, said John Ward, director of the Centers for Disease Control and Prevention’s hepatitis division, and an author of the study. “Injection drug use was fre Full Article at Omaha.com
-
This news release may contain forward-looking statements within the meaning of the federal securities laws. Statements regarding future events, developments, the Company's future performance, as well as management's expectations, beliefs, intentions, pla Full Article at Freshnews.com
-
MANITOWOC With cute names like Dancing Monkey, appealing floral scents and flavors such as cotton candy, synthetic drugs are targeting kids, authorities say. "What we're starting to hear more about is synthetic marijuana along with what people are calli Full Article at Manitowoc Herald Times Reporter
-
This patent is another validation of our commitment to developing better, more predictive tools that improve drug safety and ultimately save lives. Absorption Systems, a world leader in drug transporters, announces that a new U.S. patent issued on Januar Full Article at PRWeb
-
I faced years of mysterious illness before getting an accurate diagnosis of fibromyalgia. In this excerpt from my book FibroWHYalgia (NorseHorse Press), I share how exercise helped tame symptoms, and offer tips for others... Exercise has not always been Full Article at LifeScript
-
Your knees ache and hips creak. Did you do too much over the weekend? Or is it age? If you’re a woman in your 40s, you may have osteoarthritis, the most common form of arthritis. Find out what causes this painful joint disease and how to ease the aches a Full Article at LifeScript
-
Drugs giant AstraZeneca has received European Commission approval for its new thyroid cancer pill Caprelsa, or vandetanib. Caprelsa has been developed to treat patients with an aggressive and advanced form of the disease and is the first approved treatme Full Article at Glossop Advertiser
-
Drugs giant AstraZeneca has received European Commission approval for its new thyroid cancer pill Caprelsa, or vandetanib. Caprelsa has been developed to treat patients with an aggressive and advanced form of the disease and is the first approved treatme Full Article at Macclesfield Express
-
Drugs giant AstraZeneca has received European Commission approval for its new thyroid cancer pill Caprelsa, or vandetanib. Caprelsa has been developed to treat patients with an aggressive and advanced form of the disease and is the first approved treatme Full Article at Oldham Advertiser
